SOURCE: IO Circuit

May 04, 2006 07:30 ET Issues (AMEX: TBV) Update

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO Circuit.

LAKE HARMONY, PA -- (MARKET WIRE) -- May 4, 2006 -- Tiens Biotech (USA), Inc. (AMEX: TBV) closed up $0.18 at a price of $6.90 on 114,800 shares Wednesday. TBV was added to's "Stocks to Watch" on Tuesday morning. TBV has continued a steady trend upward since the company released their 10K on March 31st, reporting revenues of $68,688,669 U.S. with $0.41 per share earnings. In the last five days, TBV is up $1.35 on 488,000 shares. TBV traded above its annual high of $6.95 Wednesday, at one point reaching the $7.00 mark. is an online financial destination where money managers, analysts, and individual investors can converge to discover new and exciting investment news, opportunities, and ideas. is focused on finding emerging growth companies that do not necessarily have widespread analyst coverage on Wall Street.

Please visit for a TBV profile and other stocks to watch.

Other active stocks are China Bak Battery (OTC BB: CBBT), IMPCO Technologies Inc. (NASDAQ: IMCO) and China Automotive Systems Inc. (NASDAQ: CAAS).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A Third Party has hired and paid $545.00 for the publication and circulation of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.

Contact Information